Escherichia coli (cloned strain) is the core prokaryotic expression host for biological therapeutic products such as mRNA vaccines, viral vector gene therapy and CAR-T products. Host cell protein (HCP) residues generated during the production and purification process are key process-related impurities. These trace contaminants may pose an immunogenic risk and compromise the purity and safety of the finished product. HCP residue detection is a core project for process characterization, process control and product release. The key raw materials such as antigens and antibodies in this kit are all independently produced by Zhuhai Baorui Biotechnology Co., LTD. The kit has undergone comprehensive methodological performance verification in accordance with regulations such as the United States Pharmacopeia, the Chinese Pharmacopoeia, and the European Pharmacopoeia, meeting the technical requirements for HCP detection set by domestic and international biopharmaceutical regulatory authorities. The detection limit (LOD) of this kit is approximately 0.249 ng/mL, and the limit of quantification (LOQ) is approximately 0.861 ng/mL.

0756-8699969
Address: No. 88, Shuian 1st Road, Xiangzhou District, Zhuhai City, Guangdong Province
Email: marketing@biori.com
Wechat official account |
Product consultation |
Video Account |